ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,360Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 229

$903K Total Retail Price of All Prescriptions

Rank: 4 out of 229

737 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Mexico
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 737 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

14% of this provider’s 737 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

2% of this provider’s 12,646 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Mexico
LISINOPRIL 919 731 1 2
SIMVASTATIN 794 639 2 3
LEVOTHYROXINE SODIUM 672 498 3 1
OMEPRAZOLE 422 277 4 4
METFORMIN HCL 419 325 5 6
AMLODIPINE BESYLATE 390 336 6 5
LOSARTAN POTASSIUM 365 333 7 12
HYDROCODONE-ACETAMINOPHEN 344 231 S3 8 7
WARFARIN SODIUM 326 288 9 17
GABAPENTIN 269 201 10 10
FUROSEMIDE 269 237 10 8
METOPROLOL TARTRATE 260 234 12 13
ALENDRONATE SODIUM 257 207 13 14
CARVEDILOL 242 190 14 31
ATORVASTATIN CALCIUM 216 181 15 15
GLIPIZIDE 212 166 16 36
ATENOLOL 203 142 17 19
TAMSULOSIN HCL 198 169 18 24
IBUPROFEN 196 142 19 60
ZOLPIDEM TARTRATE 189 133 20 20
HYDROCHLOROTHIAZIDE 177 149 21 9
POTASSIUM CHLORIDE 175 137 22 18
FAMOTIDINE 161 136 23 84
SERTRALINE HCL 155 124 24 22
CLOPIDOGREL 150 127 25 44
PANTOPRAZOLE SODIUM 149 136 26 33
CITALOPRAM HBR 133 89 27 21
TRAMADOL HCL 125 85 28 26
CYCLOBENZAPRINE HCL 118 66 R 29 75
DONEPEZIL HCL 117 115 30 29
PLAVIX 117 103 30 72
LANTUS 113 78 32 40
DOXAZOSIN MESYLATE 109 86 33 50
MELOXICAM 107 86 34 45
LOVASTATIN 107 73 34 11
NAMENDA 106 106 36 39
ROPINIROLE HCL 106 90 36 96
ADVAIR DISKUS 101 42 38 47
NEXIUM 99 82 39 48
CIPROFLOXACIN HCL 94 75 40 58
ALLOPURINOL 93 78 41 27
CRESTOR 93 89 41 30
SYNTHROID 92 74 43 46
PREDNISONE 91 78 44 35
DILTIAZEM 24HR CD 87 75 45 89
CYMBALTA 86 54 46 64
PROPRANOLOL HCL 84 47 47 127
OXYCODONE HCL 83 28 S2 48 37
TERAZOSIN HCL 80 80 49 74
METOPROLOL SUCCINATE 76 69 50 16
LACTULOSE 73 26 51 66
CARBIDOPA-LEVODOPA 73 67 51 82
DIGOXIN 71 59 53 92
LYRICA 71 47 53 100
NIFEDIPINE ER 70 44 55 206
TRIAMCINOLONE ACETONIDE 70 39 55 113
ESCITALOPRAM OXALATE 70 66 55 98
LISINOPRIL-HYDROCHLOROTHIAZIDE 65 53 58 28
SPIRIVA 65 65 58 76
PROAIR HFA 64 26 60 38
GLYBURIDE 63 63 R 61 57
DETROL LA 63 29 61 125
TRAZODONE HCL 63 24 61 34
MIRTAZAPINE 62 61 64 52
DIOVAN 62 53 64 42
CLONIDINE HCL 58 50 66 69
LABETALOL HCL 57 44 67 143
MECLIZINE HCL 56 47 68 131
FLUOXETINE HCL 54 41 69 41
BENAZEPRIL HCL 53 53 70 86
CEPHALEXIN 50 40 71 87
LANTUS SOLOSTAR 50 26 71 85
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 22, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.